A higher effector CD8+ T‐cell/regulatory T‐cell ratio in the tumor compartment, and a higher intra‐tumoral/stromal ratio of CD8+ effector cell infiltration correlated with better overall survival in patients with NSCLC.67 The gene discussed is CD8A; the disease is non-small cell lung carcinoma.